Fish-Waste Fueled Cannabis Company Looks to IPO, Says Green Relief CEO
*By Chloe Aiello*
Warren Bravo thinks investors will get behind his fish waste-based cannabis concept when his company, Canadian marijuana producer Green Relief, heads to the public market this year.
"We are going out, we'll say, sometime this year into the IPO space," Bravo, Green Relief CEO and co-founder, told Cheddar on Wednesday, adding that he's not committed to a specific time frame.
"We want to make sure the market conditions are right, because we only have one chance to do that successfully and we want to make sure Green Relief tells the story investors want to hear."
The story that Bravo is talking about concerns cannabis and fish ー or, more specifically, fish excrement.
Green Relief has developed a system in which filtered fish waste is used to fertilize cannabis plants, which in turn, clean the water for the fish. It's a closed loop, recirculating ecosystem that enables pesticide-free farming.
"It's the same ecosystem as any freshwater lake," Bravo said. "Any vegetation that grows in water is fertilized by the fish that live in that body of water. So we've commercialized an ecosystem, and made it scale-able and growing our cannabis plants in a very natural, clean, and organic way."
Once the fish are no longer of use to the cannabis plants, Green Relief donates them to charity ー Bravo said the company has managed to provide as many as 50,000 meals to homeless shelters in the Toronto area. In the future, Bravo said Green Relief may consider monetizing the aquaculture portion of its business, and experimenting with using more valuable fish, like Asian sea bass, fresh water prawn, or koi to clean the water. But for now, Green Relief is sticking to tilapia.
"Right now tilapia is what we do, because it's tried, proven and works really well in a farmed environment. So, as they say, 'if it ain't broke don't fix it,' and that's what we are using now," Bravo said.
Bravo added that the company is "on the path to profitability," as it considers a public listing, and is currently working with lawyers to finalize its prospectus.
For full interview [click here](https://cheddar.com/videos/cannabis-and-tilapia-make-for-unlikely-but-sustainable-pairing).
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.